Market Overview:
The global Leber’s hereditary optic neuropathy (LHON) market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The dominant optic atrophy segment is expected to account for the majority share of the global LHON market in 2018. However, the recessive optic atrophy segment is projected to register a higher CAGR during the forecast period. Hospitals are anticipated to be the leading application segment of the global LHON market in 2018. However, eye clinics are projected to register a higher CAGR during the forecast period.
 (Leber Optic Atrophy) Industry Outlook.svg)
Product Definition:
Leber's hereditary optic neuropathy (LHON) is a rare, mitochondrial genetic disorder that leads to the destruction of the optic nerve. This can cause vision loss in one or both eyes, and typically occurs in young adults. There is currently no cure for LHON, but some treatments may help preserve remaining vision.
Dominant Optic Atrophy:
Dominant optic atrophy, also known as Korsakoff syndrome or cri-du-chat is a rare neurodegenerative disorder that affects one of the two eyes. The condition generally develops during early childhood and may not be evident at birth. As compared to non-dominant eye, the vision in affected person is usually normal at birth but gradually gets affected leading to loss of central vision (tunnel vision) and peripheral blindness.
Recessive Optic Atrophy:
Recessive optic atrophy (ROA) is a rare genetic disorder characterized by degeneration of the rods and cones in the eye. The disease is caused by mutations in one or more genes that control development of the retina, which is the main nerve fiber network of the eye.
The most common symptom associated with this disease includes slowly progressing visual acuity impairment followed by loss of central vision.
Application Insights:
On the basis of application, the global market is segmented into hospitals, eye clinics and medical research institutes. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities and better infrastructure in comparison with other locations. In addition, a large patient base across various regions results in high demand for Leber’s hereditary optic neuropathy (LHON) treatment at hospitals.
Medical research institutes are anticipated to witness lucrative growth over the forecast period due to increasing prevalence of target diseases worldwide as well as regional prevalence rates for Lebers hereditary optic neuropathy (LHON).
Regional Analysis:
Europe dominated the global market in 2017. The presence of well-established healthcare facilities, increased adoption of advanced treatment procedures, and high awareness levels amongst patients are some factors responsible for its large share. Moreover, a higher prevalence of dominant optic atrophy is expected to fuel the regional market during the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to increasing disposable income and growing medical tourism in emerging countries such as India and China. In addition, an increase in research funding by government organizations will boost industry development through drug discovery activities within this region thereby supporting growth during the estimated time span.
Key Players: Companies present in this space include Genentech U S A Inc.
Growth Factors:
- Increasing awareness about the disease among people and healthcare professionals
- Growing number of research studies on LHON and its potential treatments
- Development of new diagnostic techniques and therapies for LHON
- increasing incidence of LHON worldwide
- Growing demand for genetic testing services
Scope Of The Report
Report Attributes
Report Details
Report Title
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Research Report
By Type
Dominant Optic Atrophy, Recessive Optic Atrophy
By Application
Hospitals, Eye Clinics, Medical Research Institute, Other
By Companies
Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech, ProQR Therapeutics, Sanofi, Alkeus Pharmaceuticals, Stealth BioTherapeutics, Usher Syndrome
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Report Segments:
The global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market is segmented on the basis of:
Types
Dominant Optic Atrophy, Recessive Optic Atrophy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Eye Clinics, Medical Research Institute, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alkeus Pharmaceuticals
- Amgen
- Biovista
- Editas Medicine
- GenSight Biologics
- Ixchel Pharma
- Khondrion
- Mitotech
- ProQR Therapeutics
- Sanofi
- Alkeus Pharmaceuticals
- Stealth BioTherapeutics
- Usher Syndrome
 (Leber Optic Atrophy) Market Overview.svg)
Highlights of The Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dominant Optic Atrophy
- Recessive Optic Atrophy
- By Application:
- Hospitals
- Eye Clinics
- Medical Research Institute
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 (Leber Optic Atrophy) Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Leberu00e2u20acu2122s Hereditary Optic Neuropathy (LHON) is a rare inherited disorder that causes gradual vision loss in one or both eyes. The cause is unknown, but it may be caused by damage to the optic nerve, which transmits visual information from the eye to the brain. LHON usually begins slowly and progresses over time. There is no known cure for LHON, but there are treatments available that can help improve vision.
Some of the major players in the leber’s hereditary optic neuropathy (lhon) (leber optic atrophy) market are Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech, ProQR Therapeutics, Sanofi, Alkeus Pharmaceuticals, Stealth BioTherapeutics, Usher Syndrome.
The leber¢‚¬„¢s hereditary optic neuropathy (lhon) (leber optic atrophy) market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size & Forecast, 2018-2028
4.5.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size and Y-o-Y Growth
4.5.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Absolute $ Opportunity
Chapter 5 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Type
5.2.1 Dominant Optic Atrophy
5.2.2 Recessive Optic Atrophy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Eye Clinics
6.2.3 Medical Research Institute
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Analysis and Forecast
9.1 Introduction
9.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Type
9.6.1 Dominant Optic Atrophy
9.6.2 Recessive Optic Atrophy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Eye Clinics
9.10.3 Medical Research Institute
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Analysis and Forecast
10.1 Introduction
10.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Type
10.6.1 Dominant Optic Atrophy
10.6.2 Recessive Optic Atrophy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Eye Clinics
10.10.3 Medical Research Institute
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Type
11.6.1 Dominant Optic Atrophy
11.6.2 Recessive Optic Atrophy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Eye Clinics
11.10.3 Medical Research Institute
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Analysis and Forecast
12.1 Introduction
12.2 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Type
12.6.1 Dominant Optic Atrophy
12.6.2 Recessive Optic Atrophy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Eye Clinics
12.10.3 Medical Research Institute
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Type
13.6.1 Dominant Optic Atrophy
13.6.2 Recessive Optic Atrophy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Eye Clinics
13.10.3 Medical Research Institute
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market: Competitive Dashboard
14.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Alkeus Pharmaceuticals
14.3.2 Amgen
14.3.3 Biovista
14.3.4 Editas Medicine
14.3.5 GenSight Biologics
14.3.6 Ixchel Pharma
14.3.7 Khondrion
14.3.8 Mitotech
14.3.9 ProQR Therapeutics
14.3.10 Sanofi
14.3.11 Alkeus Pharmaceuticals
14.3.12 Stealth BioTherapeutics
14.3.13 Usher Syndrome
